Ehsan Jabbarzadeh
Venture Partner @ IAG Capital Partners
Ehsan Jabbarzadeh is a Series A investor at IAG Capital Partners focused on Biotechnology and Medical Device. Ehsan Jabbarzadeh is the Founder and CEO at Obsidio.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 80%
Last updated:
For AI agents: llms.txt
Industries Ehsan Jabbarzadeh invests in
Stages Ehsan Jabbarzadeh invests in
Countries Ehsan Jabbarzadeh invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 2 (40%)
- Medical Device 2 (40%)
- Medical 1 (20%)
- mHealth 1 (20%)
- Health Care 1 (20%)
Stage
- Series A 2 (40%)
- Series B 2 (40%)
- Venture - Series Unknown 1 (20%)
Country
- United States 4 (80%)
- Ireland 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| PATH EX has developed a proprietary technology to selectively separate and capture bacteria and toxins from human blood, for the treatment of sepsis. Sepsis, a life-threatening condition that commonly presents itself as a blood-borne infection, is the number one cause of death in the ICU and is the largest cost on their healthcare system. PATH EXis taking a novel approach by capturing and removing intact bacteria from the blood rather than trying to kill the infection with broad spectrum antibiotics. The PATH EX device is effective regardless of bacteria type or drug resistance. The PATH EX technology has the potential to reduce diagnostic times, treatment costs, readmission rates, and sepsis related deaths. | $5M / Venture - Series Unknown / May 08, 2025 | ||
| CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation | $16M / Series B / Aug 07, 2024 | ||
| DeepCuris builds an AI engine for small-molecule drug discovery. | $24.6M / Series A / Apr 11, 2024 | ||
| Jana Care develops and manufactures Aina Blood Monitoring Device, a novel connected blood diagnostic device.Jana Care founders Sidhant Jena, Michal Depa, and Prof. Tarun Khanna were challenged by an enterprising physician-entrepreneur (Dr. Devi Shetty) to build a smartphone app for health workers to screen for Oral Cancer and CardiovascularDisease in remote rural communities in India. What started off as a side project during graduate school, became one of the largest chronic disease screening programs in the world and eventually led to Jana Care. | $6M / Series B / Nov 08, 2023 | ||
| Lucid Scientific is a biotechnology tools company working to accelerate drug discovery and basic biological research by providing systems for real-time cellular analysis. It has invented an innovative new system for monitoring cell culture experiments. The company’s flagship technology, called RESIPHER, provides continuous and non-invasivemeasurement of oxygen consumption in a cell culture plate, then streams this information to a convenient web app. | $7M / Series A / Sep 05, 2023 |
Co-Investors
About IAG Capital Partners
IAG Capital Partners is an investment firm that sole source of financing and investment rounds with other debt and equity investors.
IAG Capital Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Alex Kash
Associate
|
|||
|
Alonso Galván
ff; Founding Principal
|
|||
|
Ehsan Jabbarzadeh
Venture Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Ehsan Jabbarzadeh invest in?
Ehsan Jabbarzadeh invests primarily in Biotechnology, Medical Device and Medical startups, most often at Series A and Series B stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ehsan Jabbarzadeh?
Public channels for Ehsan Jabbarzadeh include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Ehsan Jabbarzadeh last invest?
The most recent investment recorded for Ehsan Jabbarzadeh closed in May 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
